Results for &quot;&quot;Saquinavir&quot;&quot;[mesh_terms]

HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?

Danijela Maksimovic-Ivanic, Paolo Fagone, James McCubrey, Klaus Bendtzen, Sanja Mijatovic, Ferdinando Nicoletti

International journal of cancer 2017;140(8):1713-1726

Pharmacokinetic and tolerability profile of twice-daily saquinavir hard gelatin capsules and saquinavir soft gelatin capsules boosted with ritonavir in healthy volunteers.

M Kurowski, T Sternfeld, A Sawyer, A Hill, C Möcklinghoff

HIV medicine 2003;4(2):94-100

Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.

F Chiodo, R Manfredi

The Journal of infection 2001;42(3):181-8

Low increase in serum lipids in patients receiving a combination of ritonavir, saquinavir and efavirenz.

C Piketty, G Peytavin, A Trylezinski, G Gonzalez-Canali, P Castiel, L Weiss, M D Kazatchkine

HIV medicine 2003;3(4):287-9

Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.

Ulrik S Justesen, Zoe Fox, Court Pedersen, Pedro Cahn, Jan Gerstoft, Nathan Clumeck, Marcello Losso, Barry Peters, Niels Obel, Antonella Castagna, Ulrik B Dragsted, Jens D Lundgren

Basic & clinical pharmacology & toxicology 2007;101(5):339-44

HIV protease as a target for retrovirus vector-mediated gene therapy.

S Todd, C Anderson, D J Jolly, C S Craik

Biochimica et biophysica acta 2000;1477(1-2):168-88

Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals.

A I Veldkamp, R P van Heeswijk, J W Mulder, P L Meenhorst, G Schreij, S van der Geest, J M Lange, J H Beijnen, R M Hoetelmans

Journal of acquired immune deficiency syndromes (1999) 2001;27(4):344-9

Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus.

Y Khaliq, K Gallicano, S Venance, S Kravcik, D W Cameron

Clinical pharmacology and therapeutics 2001;68(6):637-46

Determination of interaction kinetic constants for HIV-1 protease inhibitors using optical biosensor technology.

P O Markgren, M T Lindgren, K Gertow, R Karlsson, M Hämäläinen, U H Danielson

Analytical biochemistry 2001;291(2):207-18

Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.

Kitiyaporn Wittayanarakul, Ornjira Aruksakunwong, Pornthep Sompornpisut, Vannajan Sanghiran-Lee, Vudhichai Parasuk, Surapong Pinitglang, Supot Hannongbua

Journal of chemical information and modeling 2006;45(2):300-8

Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.

Reshma Saskia Autar, Ferdinand W N M Wit, Jongkol Sankote, Duanghathai Sutthichom, Elly Kimenai, Elly Hassink, Andrew Hill, David A Cooper, Praphan Phanuphak, Joep M A Lange, David M Burger, Kiat Ruxrungtham

AIDS (London, England) 2007;21(12):1535-9

Systems Pharmacology Identifies an Arterial Wall Regulatory Gene Network Mediating Coronary Artery Disease Side Effects of Antiretroviral Therapy.

Itziar Frades, Ben Readhead, Letizia Amadori, Simon Koplev, Husain A Talukdar, Heidi M Crane, Paul K Crane, Jason C Kovacic, Joel T Dudley, Chiara Giannarelli, Johan L M Björkegren, Inga Peter

Circulation. Genomic and precision medicine 2020;12(6):e002390

Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children.

Jintanat Ananworanich, Pope Kosalaraksa, Andrew Hill, Umaporn Siangphoe, Alina Bergshoeff, Chitsanu Pancharoen, Chulapan Engchanil, Kiat Ruxrungtham, David Burger

The Pediatric infectious disease journal 2006;24(10):874-9

Drug-drug interaction study of ketoconazole and ritonavir-boosted saquinavir.

Benoite Kaeser, Hagen Zandt, Fabrice Bour, Elke Zwanziger, Christophe Schmitt, Xiaoping Zhang

Antimicrobial agents and chemotherapy 2009;53(2):609-14